Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Published:2020-11-17 Issue:2 Volume:5 Page:203-216
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatol Commun

Author:

Park Haesuk¹^ORCID,Song Hyun Jin¹^ORCID,Jiang Xinyi¹^ORCID,Henry Linda¹,Cook Robert L.²^ORCID,Nelson David R.³^ORCID

Affiliation:

1. Pharmaceutical Outcomes and Policy College of Pharmacy University of Florida Gainesville FL USA

2. Department of Epidemiology, College of Public Health and Health Professions and College of Medicine University of Florida Gainesville FL USA

3. Department of Medicine University of Florida Gainesville FL USA

Funder

National Institute on Drug Abuse

National Institute on Alcohol Abuse and Alcoholism

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1634

Reference45 articles.

1. The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010

2. Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

4. Restrictions for Medicaid Reimbursement of Sofosbuvir for the Treatment of Hepatitis C Virus Infection in the United States

5. Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changing global epidemiology of chronic hepatitis C virus-related outcomes from 2010 to 2019: cirrhosis is the growing burden of hepatitis C virus-related disease;European Journal of Cancer Prevention;2024-03-22

2. Hepatitis C in Black Individuals in the US;JAMA;2023-12-12

3. Impact of Direct-acting Antivirals on Hepatocellular Carcinoma and Mortality Among Medicaid Beneficiaries With Hepatitis C;Medical Care;2023-05-23

4. Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States;Preventive Medicine Reports;2023-04

5. Global treatment rate and barriers to direct‐acting antiviral therapy: A systematic review and meta‐analysis of 146 studies and 1 760 352 hepatitis C virus patients;Liver International;2023-03-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3